Oncogenic tyrosine kinases, DNA repair and survival: the role of Bcl-xL deamidation in transformation and genotoxic therapies.
Dysfunctional tyrosine kinases comprise an important class of oncogenes. We have generated a mouse model in which an oncogenic tyrosine kinase (OTK) causes T-lineage tumors. The model facilitates investigation of early oncogenic events in pretumorigenic thymocytes. The OTK transforms thymocytes by a 'double whammy' mechanism whereby on the one hand it inhibits DNA repair, leading to genomic instability, and on the other blocks DNA damage-induced apoptosis. The OTK-mediated blockade of apoptosis involves inhibition of DNA-damage triggered Bcl-xL deamidation, thereby preserving the protein's pro-survival functions. The pharmaceutical promotion of Bcl-xL deamidation might render cancer cells more sensitive to genotoxic attack.